Providence Capital Advisors’s Aurora Cannabis ACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1
Closed -$6 121
2024
Q3
$6 Hold
1
﹤0.01% 354
2024
Q2
$5 Hold
1
﹤0.01% 354
2024
Q1
$4 Hold
1
﹤0.01% 341
2023
Q4
$6 Hold
1
﹤0.01% 335
2023
Q3
$7 Hold
1
﹤0.01% 350
2023
Q2
$6 Hold
1
﹤0.01% 310
2023
Q1
$8 Sell
1
-1
-50% -$9 ﹤0.01% 308
2022
Q4
$18 Hold
2
﹤0.01% 297
2022
Q3
$0 Hold
2
﹤0.01% 316
2022
Q2
$0 Hold
2
﹤0.01% 287
2022
Q1
$0 Hold
2
﹤0.01% 453
2021
Q4
$0 Hold
2
﹤0.01% 337
2021
Q3
$0 Hold
2
﹤0.01% 300
2021
Q2
$0 Hold
2
﹤0.01% 305
2021
Q1
$0 Hold
2
﹤0.01% 275
2020
Q4
$0 Hold
2
﹤0.01% 316
2020
Q3
$0 Hold
2
﹤0.01% 219
2020
Q2
$0 Hold
2
﹤0.01% 184
2020
Q1
$0 Buy
2
+1
+100% +$179 ﹤0.01% 237
2019
Q4
$0 Hold
1
﹤0.01% 267
2019
Q3
$1K Hold
1
﹤0.01% 213
2019
Q2
$1K Hold
1
﹤0.01% 226
2019
Q1
$1K Hold
1
﹤0.01% 266
2018
Q4
$1K Buy
+1
New +$737 ﹤0.01% 242

Other funds holding ACB

Providence Capital Advisors's ACB Position: Q4 2024 in Review

Providence Capital Advisors sold out of Aurora Cannabis (ACB) in Q4 2024, closing a stake of 1 share — an estimated $6 sold.

Providence Capital Advisors first reported a position in ACB in Q4 2018 and held it in 24 quarters. The position peaked at $1K in Q3 2019. 168 funds tracked by Wall St. Rank hold ACB as of Q4 2024.

  • Providence Capital Advisors reported no remaining Aurora Cannabis position as of Q4 2024 after selling out during the quarter.
  • Providence Capital Advisors sold 1 Aurora Cannabis share in Q4 2024, an estimated $6.
  • Providence Capital Advisors first reported a position in Aurora Cannabis in Q4 2018 and held it in 24 quarters.
  • Providence Capital Advisors's Aurora Cannabis position peaked at $1K in Q3 2019.
  • 168 funds tracked by Wall St. Rank held Aurora Cannabis as of Q4 2024.

Based on Providence Capital Advisors's 13F filing for Q4 2024, filed 12 Feb 2025.